Epstein–Barr virus nuclear antigen-1 is useful as therapeutic efficacy marker in serum but not in saliva of nasopharyngeal cancer patients who underwent radiotherapy

INTRODUCTION: Nasopharyngeal carcinoma (NPC) is a multifactorial disease with genetic, viral, environmental and lifestyle-related risk factors. Epstein–Barr virus (EBV) can promote the oncogenic transformation of an infected cell into malignant. EBV encodes many stimulating products including Epstei...

Descripción completa

Detalles Bibliográficos
Autores principales: Midoen, Yurnadi H, Suryandari, Dwi A, Yunaini, Luluk, Susworo, Raden, Auerkari, Elza I, Freisleben, Hans-Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241448/
https://www.ncbi.nlm.nih.gov/pubmed/34267810
http://dx.doi.org/10.3332/ecancer.2021.1254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241448/
https://www.ncbi.nlm.nih.gov/pubmed/34267810
http://dx.doi.org/10.3332/ecancer.2021.1254

Ejemplares similares